Reuters -- Swiss drugmaker Novartis is buying an 85 percent stake in privately owned Chinese vaccines company Zhejiang Tianyuan for $125 million to boost its presence in the fast-growing market, it said on Wednesday.
Reuters -- Swiss drugmaker Novartis is buying an 85 percent stake in privately owned Chinese vaccines company Zhejiang Tianyuan for $125 million to boost its presence in the fast-growing market, it said on Wednesday.
